- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (01/10/2018)
- Gwreiddiol (a wnaed Fel)
Version Superseded: 17/05/2024
Point in time view as at 01/10/2018.
There are currently no known outstanding effects for the The Veterinary Medicines Regulations 2013, SCHEDULE 3.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Regulation 7
PART 1 Classification and supply of authorised veterinary medicinal products
1.Classification of veterinary medicinal products
2.Wholesale supply of veterinary medicinal products
3.Retail supply of veterinary medicinal products
4.Prescriptions by a veterinary surgeon
5.Prescriptions
6.Written prescriptions
7.Duties when a product is prescribed or supplied
8.Supply by a veterinary surgeon from registered premises
9.Supply by a veterinary surgeon
10.Supply by a pharmacist
11.Supply of a veterinary medicinal product for incorporation into feedingstuffs
12.Labelling at the time of retail supply
13.Supply of veterinary medicinal products for use under the cascade
14.Supply by a suitably qualified person
15.Annual audit
PART 2 Requirements for a wholesale dealer’s authorisation
16.Application
17.Time limits
18.Granting the authorisation
19.The authorisation
20.Suspension, variation or revocation of the authorisation
21.Duties on the holder of a wholesale dealer’s authorisation
PART 3 Sheep dip
22.Supply of sheep dip
23.Use of sheep dip
24.Offences
1.—(1) There shall be the following categories of authorised veterinary medicinal products—
(a)Prescription Only Medicine–Veterinarian (abbreviated to POM-V);
(b)Prescription Only Medicine–Veterinarian, Pharmacist, Suitably Qualified Person (abbreviated to POM-VPS);
(c)Non-Food Animal–Veterinarian, Pharmacist, Suitably Qualified Person (abbreviated to NFA-VPS);
(d)Authorised Veterinary Medicine–General Sales List (abbreviated to AVM-GSL).
(2) The Secretary of State must specify the classification of the veterinary medicinal product when granting the initial marketing authorisation.
(3) The Secretary of State may change the classification after the marketing authorisation has been granted, either at the request of the marketing authorisation holder or in accordance with paragraph 37 of Schedule 1 (compulsory variation).
(4) When granting the marketing authorisation the Secretary of State must classify the following as POM-V—
(a)products containing narcotic or psychotropic substances;
(b)products intended for administration following a diagnosis or clinical assessment by a veterinary surgeon.
(5) When granting the marketing authorisation the Secretary of State must classify the following as POM-V or POM-VPS—
(a)products for food-producing animals;
(b)products in respect of which special precautions must be taken in order to avoid any unnecessary risk to—
(i)the target species;
(ii)the person administering the products to the animal; and
(iii)the environment;
(c)products that may cause effects that impede or interfere with subsequent diagnostic or therapeutic measures; and
(d)new veterinary medicinal products containing an active substance that has not been included in an authorised veterinary medicinal product for five years.
(6) The requirement in sub-paragraph (5)(a) relating to veterinary medicinal products for food-producing animals does not apply if all the following criteria are met—
(a)the administration of the veterinary medicinal product is restricted to formulations requiring no particular knowledge or skill in using the product;
(b)the veterinary medicinal product does not present a direct or indirect risk, even if administered incorrectly, to the animal or animals treated, to the person administering the product or to the environment;
(c)the summary of product characteristics of the veterinary medicinal product does not contain any warnings of potential serious side effects deriving from its correct use;
(d)neither the veterinary medicinal product nor any other product containing the same active substance has previously been the subject of frequent serious adverse reaction reporting;
(e)the summary of product characteristics does not refer to contra-indications related to other veterinary medicinal products commonly used without prescription;
(f)the veterinary medicinal product is not subject to special storage conditions;
(g)there is no risk for consumer safety as regards residues in food obtained from treated animals even where the veterinary medicinal products are used incorrectly; and
(h)there is no risk to human or animal health as regards the development of resistance to antimicrobials or anthelmintic substances even where the veterinary medicinal products containing those substances are used incorrectly.
2.—(1) Only a holder of a marketing authorisation, the holder of a manufacturing authorisation or the holder of a wholesale dealer’s authorisation granted by the Secretary of State may supply a veterinary medicinal product wholesale, or be in possession of it for that purpose.
(2) A person mentioned in sub-paragraph (1) may only supply a veterinary medicinal product if—
(a)the authorisation in question relates to that product, and
(b)the supply is to another person who is entitled to supply that product under these Regulations, either wholesale or retail.
(3) If the supply is to a suitably qualified person, it must be to the premises approved in accordance with paragraph 14.
(4) It is immaterial whether or not the supply is for profit.
(5) This paragraph does not apply in relation to a retailer of veterinary medicinal products who supplies another retailer with such products for the purpose of alleviating a temporary supply shortage that could be detrimental to animal welfare.
(6) A wholesale dealer may break open any package (other than the immediate packaging) of a veterinary medicinal product.
3.—(1) This paragraph applies in relation to retail supply of veterinary medicinal products.
(2) A veterinary medicinal product classified as POM-V may only be supplied by a veterinary surgeon or a pharmacist and must be supplied in accordance with a prescription from a veterinary surgeon.
(3) A veterinary medicinal product classified as POM-VPS may only be supplied by—
(a)a veterinary surgeon;
(b)a pharmacist; or
(c)a suitably qualified person in accordance with paragraph 14,
and must be in accordance with a prescription from one of those persons.
(4) A veterinary medicinal product classified as NFA-VPS may be supplied without prescription, but may only be supplied by—
(a)a veterinary surgeon;
(b)a pharmacist; or
(c)a suitably qualified person in accordance with paragraph 14.
(5) There are no restrictions on the supply of AVM-GSL products.
(6) In this paragraph—
(a)“retail supply” means any supply other than to or from the holder of a wholesale dealer’s authorisation, and whether or not for payment; and
(b)a person may supply a product irrespective of who owns it.
4.—(1) A veterinary surgeon who prescribes a veterinary medicinal product classified as POM-V must first carry out a clinical assessment of the animal, and the animal must be under that veterinary surgeon’s care.
(2) This does not apply in relation to the administration of such a product to a wild animal where the administration is authorised by the Secretary of State.
5.—(1) A prescription may be oral or written, but a veterinary medicinal product classified as POM-V or POM-VPS may only be supplied—
(a)by the person who prescribed it;
(b)under a written prescription that complies with paragraph 6; or
(c)(in the case of POM-VPS) by a suitably qualified person in accordance with paragraph 14(5).
(2) A person supplying such a product under a written prescription—
(a)may only supply the product specified in that prescription;
(b)must take all reasonable steps to be satisfied that the prescription has been written and signed by a person entitled to prescribe the product; and
(c)must take all reasonable steps to ensure that it is supplied to the person named in the prescription.
(3) No person may alter a written prescription unless authorised to do so by the person who signed it.
6.—(1) A written prescription must include—
(a)the name, address and telephone number of the person prescribing the product;
(b)the qualifications enabling the person to prescribe the product;
(c)the name and address of the owner or keeper;
(d)the identification (including the species) of the animal or group of animals to be treated;
(e)the premises at which the animals are kept if this is different from the address of the owner or keeper;
(f)the date of the prescription;
(g)the signature or other authentication of the person prescribing the product;
(h)the name and amount of the product prescribed;
(i)the dosage and administration instructions;
(j)any necessary warnings;
(k)the withdrawal period if relevant; and
(l)if it is prescribed under the cascade, a statement to that effect.
(2) A written prescription for a controlled drug as specified in Schedules 2 to 4 of the Misuse of Drugs Regulations 2001(1) is valid for 28 days.
(3) A written prescription for any other drug is valid for six months or such shorter period as may be specified in the prescription.
(4) If the prescription is repeatable it must specify the number of times the veterinary medicinal product may be supplied.
7. A person who prescribes a product classified as POM-V or POM-VPS, or supplies a product classified as NFA-VPS—
(a)before doing so, must be satisfied that the person who will use the product is competent to do so safely, and intends to use it for a purpose for which it is authorised;
(b)when doing so, must advise on its safe administration and on any warnings or contra-indications on the label or package leaflet; and
(c)must not prescribe (or, in the case of a NFA-VPS product, supply) more than the minimum amount required for the treatment; but it is a defence to a charge of failing to comply with this paragraph to show that—
(i)the product prescribed or supplied was in a container specified in the marketing authorisation;
(ii)the manufacturer does not supply that veterinary medicinal product in a smaller container; and
(iii)the person prescribing or supplying is not a person authorised to break open the package before supply.
8.—(1) A veterinary surgeon may only supply a veterinary medicinal product from practice premises registered with the Royal College of Veterinary Surgeons as veterinary practice premises at which veterinary medicinal products are stored or supplied.
(2) This paragraph does not apply in relation to a veterinary medicinal product classified as AVM-GSL.
(3) The Royal College of Veterinary Surgeons must, on request, supply the Secretary of State with a copy of the register of veterinary practice premises.
(4) The Secretary of State must, from time to time, inspect premises registered under sub-paragraph (1), basing the frequency of the inspection on the risks associated with each premises’ history and the nature of the products handled at the premises.
(5) Where an inspection under sub-paragraph (4) reveals significant breaches of these Regulations the Secretary of State may require the Royal College of Veterinary Surgeons to remove the premises from the register maintained under sub-paragraph (1).
(6) Where the Secretary of State requires the removal of premises from the register the veterinary surgeon concerned may appeal using the procedure in regulation 30.
(7) Where premises have been removed from the register under sub-paragraph (5) they may not be re-registered without the approval of the Secretary of State.
(8) The Secretary of State may only grant approval under sub-paragraph (7) after a further inspection of the premises.
9.—(1) A veterinary surgeon supplying a veterinary medicinal product (other than one classified as AVM-GSL) must be present when it is handed over unless the veterinary surgeon—
(a)authorises each transaction individually before the product is supplied; and
(b)is satisfied that the person handing it over is competent to do so.
(2) A veterinary surgeon or a person acting under a veterinary surgeon’s responsibility may open any package containing a veterinary medicinal product.
10.—(1) A pharmacist may only supply a veterinary medicinal product classified as POM-V, POM-VPS or NFA-VPS from—
(a)premises registered as a pharmacy with the General Pharmaceutical Council or with the Pharmaceutical Society of Northern Ireland;
(b)premises registered with the Royal College of Veterinary Surgeons as being premises from which a veterinary surgeon supplies veterinary medicinal products; or
(c)(in the case of a veterinary medicinal product classified as POM-VPS or NFA-VPS) from premises approved under paragraph 14.
(2) A pharmacist supplying a veterinary medicinal product (other than one classified as AVM-GSL) must be present when it is handed over unless the pharmacist—
(a)authorises each transaction individually before the product is supplied; and
(b)is satisfied that the person handing it over is competent to do so.
(3) A pharmacist may supply any veterinary medicinal product prepared in a pharmacy in accordance with the prescriptions of a pharmacopoeia and intended to be supplied directly to the end-user.
(4) A pharmacist may supply a homeopathic remedy prepared extemporaneously by a pharmacist in a registered pharmacy (as well as any other homeopathic remedy permitted to be supplied by a pharmacist under these Regulations) provided that it is prepared in accordance with paragraph 63 of Schedule 1 and intended to be supplied directly to the end user.
(5) A pharmacist may break open any package containing a veterinary medicinal product for the purposes of supply other than the immediate packaging of an injectable product.
11.—(1) This paragraph applies in relation to the supply of a veterinary medicinal product intended for incorporation into feedingstuffs.
(2) The marketing authorisation holder, an authorised manufacturer of the product or an authorised wholesale dealer may only supply such a veterinary medicinal product to—
(a)a veterinary surgeon, pharmacist or, in the case of a product classified as POM-VPS, a suitably qualified person;
(b)an approved premixture manufacturer; or
(c)an approved feedingstuffs manufacturer if the approval permits the rate of incorporation specified on the label of that veterinary medicinal product (if the manufacturer is the end-user the supply must be in accordance with a prescription).
(3) A veterinary surgeon, pharmacist or, in the case of a product classified as POM-VPS, a suitably qualified person may only supply such a veterinary medicinal product to—
(a)an approved premixture manufacturer; or
(b)an approved feedingstuffs manufacturer if the approval permits the rate of incorporation specified on the label of that veterinary medicinal product (if the manufacturer is the end user the supply must be in accordance with a prescription).
(4) An approved premixture manufacturer or an approved feedingstuffs manufacturer may only supply such a veterinary medicinal product to another approved premixture manufacturer or approved feedingstuff manufacturer if the amount supplied does not exceed five per cent in terms of value of veterinary medicinal product incorporated annually by the person supplying the veterinary medicinal product.
12.—(1) If a veterinary medicinal product is supplied in a container specified in the marketing authorisation, it must not be supplied if any information on the outer packaging (or, if there is no outer packaging, the immediate packaging) is not clearly visible at the time of supply or has been changed in any way.
(2) Sub-paragraph (1) does not apply to a veterinary surgeon who amends a label, or a pharmacist who amends it in accordance with a prescription from a veterinary surgeon, provided that the unamended information remains clearly visible.
(3) If a veterinary medicinal product is supplied in a container other than that specified in the marketing authorisation, the person supplying the veterinary medicinal product must ensure that the container is suitably labelled and must supply sufficient written information (which may include a copy of the summary of product characteristics or the package leaflet) to enable the product to be used safely.
13.—(1) A veterinary medicinal product supplied for administration under the cascade may only be supplied in accordance with a prescription from a veterinary surgeon.
(2) Unless the veterinary surgeon who prescribed the veterinary medicinal product both supplies the product and administers it to the animal in person, the person supplying it must label it (or ensure that it is labelled) with at least the following information—
(a)the name and address of the pharmacy, veterinary surgery or approved premises supplying the veterinary medicinal product;
(b)the name of the veterinary surgeon who has prescribed the product;
(c)the name and address of the animal owner;
(d)the identification (including the species) of the animal or group of animals;
(e)the date of supply;
(f)the expiry date of the product, if applicable;
(g)the name or description of the product, which should include at least the name and quantity of active ingredients;
(h)dosage and administration instructions;
(i)any special storage precautions;
(j)any necessary warnings for the user, target species, administration or disposal of the product;
(k)the withdrawal period, if relevant; and
(l)the words “Keep out of reach of children” and “For animal treatment only”.
14.—(1) The Secretary of State may recognise bodies that are suitable to maintain a register for suitably qualified persons to prescribe and supply veterinary medicinal products classified as POM-VPS and NFA-VPS.
(2) In order to recognise such a body, the Secretary of State must be satisfied that the body—
(a)has in place a system for ensuring that persons applying for registration have adequate training to act as a suitably qualified person under these Regulations;
(b)has adequate standards in deciding whether or not to register someone as a suitably qualified person;
(c)maintains a programme of continuing professional development for persons registered with it;
(d)operates an adequate appeal system if it intends to refuse to register anyone with appropriate qualifications or to remove anyone from the register.
(3) For the purposes of these Regulations, a suitably qualified person is a person who has passed examinations specified by such a body, and is registered with such a body as a suitably qualified person.
(4) A suitably qualified person may only supply a veterinary medicinal product classified as POM-VPS, NFA-VPS or AVM-GSL, and may only supply it from—
(a)premises approved by the Secretary of State as being suitable for the storage and supply of veterinary medicinal products by a suitably qualified person;
(b)premises registered as a pharmacy with the General Pharmaceutical Council or with the Pharmaceutical Society of Northern Ireland; or
(c)practice premises registered under these Regulations as being premises from which a veterinary surgeon supplies veterinary medicinal products.
(5) A suitably qualified person who supplies a product classified as POM-VPS or NFA-VPS must either—
(a)hand over or despatch the product personally;
(b)ensure that, when the product is handed over or despatched, the suitably qualified person is in a position to intervene if necessary; or
(c)check the product after it has been allocated for supply to a customer, and be satisfied that the person handing over or dispatching it is competent to do so.
(6) A suitably qualified person supplying products from premises approved under this regulation by the Secretary of State who considers that the premises no longer comply with the approval must notify the Secretary of State without unreasonable delay.
(7) The Secretary of State may issue a Code of Practice for suitably qualified persons, and a body recognised under this paragraph must take appropriate action in accordance with any disciplinary code that applies to that body if a suitably qualified person registered with it does not comply with the Code of Practice.
(8) The Secretary of State must publish a list of—
(a)suitably qualified persons; and
(b)the trading names and the addresses of premises approved under this paragraph(2).
(9) A suitably qualified person may break open any package (other than the immediate packaging) of a veterinary medicinal product.
(10) The Secretary of State may suspend or revoke the approval of approved premises on being satisfied that they are no longer suitable for the storage and supply of veterinary medicinal products.
15. At least once a year every person entitled to supply a veterinary medicinal product on prescription must carry out a detailed audit, and incoming and outgoing veterinary medicinal products must be reconciled with products currently held in stock, any discrepancies being recorded.
16. An application for a wholesale dealer’s authorisation must be made to the Secretary of State.
17. The Secretary of State must process an application for a wholesale dealer’s authorisation within 90 days of receiving it.
18.—(1) The Secretary of State must grant a wholesale dealer’s authorisation on being satisfied that this paragraph is complied with.
(2) The authorised site must be—
(a)weatherproof;
(b)secure and lockable;
(c)clean; and
(d)free from contaminants.
(3) If the veterinary medicinal products covered by the authorisation are subject to specific storage conditions, the site must be capable of fulfilling those requirements.
(4) The authorisation holder must—
(a)have the services of technically competent staff; and
(b)have an effective emergency recall plan.
19.—(1) The wholesale dealer’s authorisation must specify—
(a)the types of veterinary medicinal products and pharmaceutical forms that may be dealt in;
(b)the place where they are to be stored;
(c)the name and address of the person holding the authorisation;
(d)the address of the premises to which it relates;
(e)the name of the qualified person nominated to act under the Guidelines on Good Distribution Practice for Human Use(3).
(2) It may cover more than one site.
(3) It lapses if the holder does not deal in veterinary medicinal products for five years.
(4) The holder of a wholesale dealer’s authorisation must notify the Secretary of State, and if necessary apply for a variation of the authorisation, before making a material alteration to the premises or facilities used under the authorisation, or in the operations for which they are used.
20. The Secretary of State may suspend, vary or revoke a wholesale dealer’s authorisation if the holder—
(a)has not complied with these Regulations; or
(b)no longer has suitable premises or equipment.
21. The holder of a wholesale dealer’s authorisation must—
(a)store veterinary medicinal products in accordance with the terms of the marketing authorisation for each product;
(b)comply with the Guidelines on Good Distribution Practice of Medicinal Products for Human Use as if the veterinary medicinal products were authorised human medicinal products;
(c)carry out a detailed stock audit at least once a year; and
(d)supply information and samples to the Secretary of State on demand.
22.—(1) A person who supplies by retail sheep dip which contains a veterinary medicinal product must supply it in accordance with this paragraph.
(2) The supply must be to a person (or a person acting on that person’s behalf) who is qualified to use it in accordance with paragraph 23.
(3) The supplier must make a record of that person’s certificate or award number as soon as is reasonably practicable, and keep it for at least three years.
(4) If the active ingredient of the veterinary medicinal product is an organophosphorus compound, the supplier must give to the buyer—
(a)a double-sided laminated notice meeting the specifications in the following sub-paragraph (unless the notice has been provided to the buyer within the previous twelve months and the supplier knows or has reasonable cause to believe that the buyer still has it available for use); and
(b)two pairs of gloves either as described in the notice or providing demonstrably superior protection to the proposed user against exposure to the dip than would be provided by gloves as so described.
(5) The notice must be at least A4 size with a laminated transparent cover and must tell the user of the sheep dip—
(a)to read and act in accordance with the label, including instructions on measuring and diluting concentrate;
(b)that sheep dip is absorbed through the skin;
(c)always to wear the recommended protective clothing, including gloves, and have spare protective clothing available;
(d)always to wash protective clothing before taking it off; and
(e)to direct any questions to the supplier or manufacturer.
(6) The notice must contain a diagram showing recommended protective clothing.
23.—(1) No person may use sheep dip which contains a veterinary medicinal product unless the person is acting under the supervision and in the presence of, a person who holds either—
(a)a Certificate of Competence in the Safe Use of Sheep Dips showing that Parts 1 and 2 or units 1 and 2 of the assessment referred to in the Certificate have been satisfactorily completed; or
(b)NPTC Level 2 Award in the Safe Use of Sheep Dip (QCF).
(2) The certificate must be issued—
(a)in England, Wales and Northern Ireland; by—
(i)the National Proficiency Tests Council;
(ii)NPTC Part of the City & Guilds Group; or
(iii)City and Guilds NPTC;
(b)in Scotland, by one of those organisations or the Scottish Skills Testing Service.
24. It is an offence to fail to comply with—
(a)paragraph 2;
(b)paragraph 3;
(c)paragraph 4(1);
(d)paragraph 5;
(e)paragraph 7;
(f)paragraph 8(1);
(g)paragraph 9(1);
(h)paragraph 10;
(i)paragraph 11;
(j)paragraph 12(1) or (3);
(k)paragraph 13;
(l)paragraph 14(4), (5) or (6);
(m)paragraph 15;
(n)paragraph 19(4);
(o)paragraph 21;
(p)paragraph 22; or
(q)paragraph 23(1).
S. I. 2001/3998; relevant amending instruments are S. I. 2003/1432 and 2005/1653.
Published at: http://www.vmd.defra.gov.uk/registers/sqpregister.aspx.
OJ No C 63, 1.3.94, p. 4.
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
Yr Offeryn Cyfan you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Rhestrau you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys